» Articles » PMID: 22749592

Potential Impact of Parental Tdap Immunization on Infant Pertussis Hospitalizations

Overview
Journal Vaccine
Date 2012 Jul 4
PMID 22749592
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

We estimated the potential impact of parental Tdap immunization before delivery, at delivery and at the 2-week newborn visit on U.S. infant pertussis hospitalizations. We used published data for pertussis hospitalization rates among U.S. infants aged 0-4 months, the Tdap vaccine efficacy in adults, and the proportion of infants with pertussis <6 months of age in which either parent was the source (16-40% from mothers and 16-20% from fathers). Immunizing parents before pregnancy or ≥ 2 weeks prior to delivery should reduce pertussis hospitalizations among infants 0-4 months by 2694-9314 if both parents are vaccinated, and by 1347-6909 if only mothers are vaccinated. Greater reductions in pertussis hospitalizations would be achieved if parents are immunized ≥ 2 weeks prior to delivery than after delivery or the 2-week newborn visit. Although immunizing parents prior to pregnancy or delivery is best, immunizing parents in the postpartum period should provide protection to that newborn and to infants of subsequent pregnancies.

Citing Articles

The National Vaccine Advisory Committee: reducing patient and provider barriers to maternal immunizations: approved by the National Vaccine Advisory Committee on June 11, 2014.

Public Health Rep. 2015; 130(1):10-42.

PMID: 25552752 PMC: 4245282. DOI: 10.1177/003335491513000104.


How to fight pertussis?.

Guiso N Ther Adv Vaccines. 2014; 1(2):59-66.

PMID: 24757515 PMC: 3967663. DOI: 10.1177/2051013613481348.


Does googling for preconception care result in information consistent with international guidelines: a comparison of information found by Italian women of childbearing age and health professionals.

Agricola E, Gesualdo F, Pandolfi E, Gonfiantini M, Carloni E, Mastroiacovo P BMC Med Inform Decis Mak. 2013; 13:14.

PMID: 23347453 PMC: 3598770. DOI: 10.1186/1472-6947-13-14.

References
1.
Tomovici A, Barreto L, Zickler P, Meekison W, Noya F, Voloshen T . Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine. Vaccine. 2012; 30(16):2647-53. DOI: 10.1016/j.vaccine.2012.02.013. View

2.
Wendelboe A, Njamkepo E, Bourillon A, Floret D, Gaudelus J, Gerber M . Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J. 2007; 26(4):293-9. DOI: 10.1097/01.inf.0000258699.64164.6d. View

3.
Durand C, Flament E . [Pertussis vaccination for parents: proposal and evaluation of two professional practices in a maternity hospital]. Arch Pediatr. 2011; 18(4):362-9. DOI: 10.1016/j.arcped.2011.01.013. View

4.
OBrien J, Caro J . Hospitalization for pertussis: profiles and case costs by age. BMC Infect Dis. 2005; 5:57. PMC: 1184075. DOI: 10.1186/1471-2334-5-57. View

5.
Chuk L, Lambert S, May M, Beard F, Sloots T, Selvey C . Pertussis in infants: how to protect the vulnerable?. Commun Dis Intell Q Rep. 2009; 32(4):449-56. View